Ethyl 4-nitrobenzoate

Names

[ CAS No. ]:
99-77-4

[ Name ]:
Ethyl 4-nitrobenzoate

[Synonym ]:
Ethyl para-nitrobenzoate
4-Nitrobenzoic acid ethyl ester
Benzoic acid, 4-nitro-, ethyl ester
ethyl p-nitrobenzoate
MFCD00007351
ethyl 4-nitrobenzoate
EINECS 202-786-2

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
315.0±25.0 °C at 760 mmHg

[ Melting Point ]:
55-59 °C(lit.)

[ Molecular Formula ]:
C₉H₉NO₄

[ Molecular Weight ]:
195.172

[ Flash Point ]:
148.2±25.2 °C

[ Exact Mass ]:
195.053162

[ PSA ]:
72.12000

[ LogP ]:
2.33

[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C

[ Index of Refraction ]:
1.545

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: DH5600000

CHEMICAL NAME :: Benzoic acid, p-nitro-, ethyl ester

CAS REGISTRY NUMBER :: 99-77-4

BEILSTEIN REFERENCE NO. :: 1912879

LAST UPDATED :: 199709

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C9-H9-N-O4

MOLECULAR WEIGHT :: 195.19

WISWESSER LINE NOTATION :: WNR DVO2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 250 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD691-490

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
R33

[ Safety Phrases ]:
S22-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
DH5600000

[ HS Code ]:
2916399090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Customs

[ HS Code ]: 2916399090

[ Summary ]:
2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems.

Regul Toxicol Pharmacol 70(1) , 182-8, (2014)

The clinical use of local anesthetic products to anesthetize mucous membranes has been associated with methemoglobinemia (MetHba), a serious condition in which the blood has reduced capacity to carry ...